62 related articles for article (PubMed ID: 38352733)
1. RUNX1-BMP2 promotes vasculogenic mimicry in laryngeal squamous cell carcinoma via activation of the PI3K-AKT signaling pathway.
Zhu Q; Zhang X; Lu F; Miao S; Zhang C; Liu Z; Gao Z; Qi M; An X; Geng P; Wang S; Ren H; Han F; Zhang R; Zha D
Cell Commun Signal; 2024 Apr; 22(1):227. PubMed ID: 38610001
[TBL] [Abstract][Full Text] [Related]
2. Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatment.
Wang X; Cao K; Guo E; Mao X; An C; Guo L; Zhang C; Guo J; Yang X; Sun J; Yang W; Li X; Miao S
Cancer Immunol Immunother; 2022 May; 71(5):1199-1220. PubMed ID: 34643766
[TBL] [Abstract][Full Text] [Related]
3. Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape.
Zhang XY; Shi JB; Jin SF; Wang RJ; Li MY; Zhang ZY; Yang X; Ma HL
Cancer Commun (Lond); 2024 May; ():. PubMed ID: 38734931
[TBL] [Abstract][Full Text] [Related]
4. Blocking siglec-10
Xiao N; Zhu X; Li K; Chen Y; Liu X; Xu B; Lei M; Xu J; Sun HC
Exp Hematol Oncol; 2021 Jun; 10(1):36. PubMed ID: 34112250
[TBL] [Abstract][Full Text] [Related]
5. BCL11A Promotes the Progression of Laryngeal Squamous Cell Carcinoma.
Zhou J; Zhou L; Zhang D; Tang WJ; Tang D; Shi XL; Yang Y; Zhou L; Liu F; Yu Y; Liu P; Tao L; Lu LM
Front Oncol; 2020; 10():375. PubMed ID: 32266150
[No Abstract] [Full Text] [Related]
6. Comprehensive analysis of the immune implication of EPHX4 gene in laryngeal squamous cell carcinoma.
Shen N; Gao G; Lu X; Jin J; Lin L; Qian M; Qin Y
Braz J Otorhinolaryngol; 2024 Mar; 90(4):101411. PubMed ID: 38663041
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic analysis reveals prognostic value and immunotherapy potential of Siglec-15 in laryngeal squamous cell carcinoma.
Chen X; Cai Q; Wong K; Shen X; Guan Z
Heliyon; 2024 Feb; 10(3):e25266. PubMed ID: 38352733
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
9. [Study on the effect and mechanisms of SIGLEC-15 on laryngeal squamous cell carcinoma].
Li SH; Sun J; Chen W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jun; 57(6):724-731. PubMed ID: 35725316
[No Abstract] [Full Text] [Related]
10. Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.
Li JD; Chen Y; Jing SW; Wang LT; Zhou YH; Liu ZS; Song C; Li DZ; Wang HQ; Huang ZG; Dang YW; Chen G; Luo JY
Eur J Med Res; 2023 Dec; 28(1):591. PubMed ID: 38102653
[TBL] [Abstract][Full Text] [Related]
11. The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma.
Yang C; Cao H; Yang JW; Liu T; Wang JT; Wang BS
Neoplasma; 2021 Nov; 68(6):1212-1224. PubMed ID: 34585589
[TBL] [Abstract][Full Text] [Related]
12. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
Qian L; Ni T; Fei B; Sun H; Ni H
BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
[TBL] [Abstract][Full Text] [Related]
13. Siglec-15 as a New Perspective Therapy Target in Human Giant Cell Tumor of Bone.
Fan M; Zhang G; Xie M; Liu X; Zhang Q; Wang L
Curr Oncol; 2022 Oct; 29(10):7655-7671. PubMed ID: 36290882
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
